About 4.4% of the global population currently lives with a diagnosed anxiety disorder, which translates to roughly 359 million people worldwide. That makes anxiety the single most common mental health condition on the planet. In the United States, the numbers are significantly higher: nearly 1 in 5 American adults experience an anxiety disorder in any given year, and the rate among teenagers is even steeper.
Global Prevalence at a Glance
The World Health Organization estimates that 359 million people had an anxiety disorder in 2021. At 4.4% of the world’s population, anxiety disorders outnumber depression, bipolar disorder, and every other mental health condition. And that figure likely undercounts the true burden, since millions of people in low- and middle-income countries never receive a formal diagnosis.
The economic toll is enormous. An estimated 12 billion working days are lost globally each year to anxiety and depression combined, costing roughly $1 trillion annually in lost productivity.
Rates in the United States
Anxiety is far more prevalent in the U.S. than the global average suggests. Data from the National Comorbidity Survey found that 19.1% of American adults met the criteria for an anxiety disorder within the past year. Women are affected at notably higher rates than men: 23.4% of women compared to 14.3% of men.
Among American adolescents, the numbers climb even higher. About 31.9% of teens experience an anxiety disorder, with 38% of adolescent girls affected compared to 26.1% of boys. For younger children ages 3 to 17, the CDC reports that 11% have a current, diagnosed anxiety condition based on 2022-2023 data.
Why Women and Girls Are More Affected
Across every age group and nearly every country studied, women and girls develop anxiety disorders at roughly 1.5 to 2 times the rate of men and boys. This gap appears as early as adolescence and persists throughout adulthood. Researchers attribute it to a combination of hormonal differences, higher sensitivity to stress-related brain signaling, and greater exposure to certain risk factors like interpersonal violence and caregiving stress. The gap is not simply a matter of women being more willing to report symptoms; it shows up consistently in structured diagnostic interviews where both genders are assessed the same way.
Breakdown by Type of Anxiety Disorder
“Anxiety disorder” is an umbrella term covering several distinct conditions, each with its own prevalence in the U.S. adult population:
- Specific phobias are the most common, affecting 19.3 million adults (9.1%). These involve intense, irrational fear of particular things like heights, flying, spiders, or blood.
- Social anxiety disorder affects 15 million adults (7.1%). It goes well beyond shyness, causing significant distress around everyday social interactions like meetings, conversations, or eating in public.
- Generalized anxiety disorder (GAD) affects 6.8 million adults (3.1%). People with GAD experience persistent, hard-to-control worry about multiple areas of life for six months or longer.
- Panic disorder affects 6 million adults (2.7%). It involves recurring, unexpected panic attacks along with ongoing fear of having another one.
Many people meet the criteria for more than one type simultaneously, which is why individual disorder percentages don’t simply add up to the overall prevalence figure.
How COVID-19 Changed the Numbers
The pandemic made a bad situation measurably worse. In the first year of COVID-19, global prevalence of anxiety and depression increased by 25%, according to a WHO scientific brief. Lockdowns, social isolation, fear of infection, grief, and financial uncertainty all contributed. Young people and women were disproportionately affected.
While some of that spike has eased as pandemic restrictions lifted, anxiety rates have not fully returned to pre-2020 levels in most countries. The pandemic essentially accelerated trends that were already moving in the wrong direction, particularly among adolescents and young adults who were already showing rising anxiety rates before 2020.
The Treatment Gap
Despite being highly treatable, anxiety disorders go untreated in the majority of cases worldwide. Only about a third of people with anxiety in high-income countries receive any form of professional help, and in low-income countries the figure drops to less than 10%. Even in the United States, where mental health services are comparatively accessible, many people wait years between the onset of symptoms and their first appointment. The average delay is over a decade for some anxiety disorders.
Several barriers drive this gap. Many people don’t recognize their symptoms as a treatable condition, particularly if they’ve lived with chronic worry or avoidance for most of their lives. Stigma, cost, and limited availability of trained providers all play a role. For specific phobias and social anxiety in particular, the nature of the condition itself can make seeking help feel overwhelming.
What These Numbers Mean in Context
If 4.4% sounds low compared to the U.S. figure of nearly 20%, that’s partly a reflection of how different countries screen for and diagnose mental health conditions. Countries with less access to mental health care report lower prevalence, not because fewer people are anxious, but because fewer people are evaluated. The true global figure is almost certainly higher than 4.4%.
It’s also worth noting the difference between having an anxiety disorder and experiencing anxiety. Everyone feels anxious sometimes. The prevalence figures above refer specifically to people whose anxiety is persistent, difficult to control, and disruptive enough to meet clinical diagnostic criteria. The number of people dealing with elevated anxiety that falls short of a formal diagnosis is substantially larger. Surveys that ask about anxiety symptoms rather than diagnosable disorders consistently produce higher numbers, sometimes reaching 30% or more of adults in a given year.